Estradiol attenuates angiotensin-induced aldosterone secretion in ovariectomized rats

Endocrinology

Volumn 141, Issue 12, 2000, Pages 4629-4636

  Roesch, Darren M ^a,b   Tian, Ying ^a   Zheng, Wei ^a   Shi, Min ^a   Verbalis, Joseph G ^a   Sandberg, Kathryn ^a  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b 350 Building D ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR; CORTICOTROPIN; DEXAMETHASONE; ESTRADIOL; ESTROGEN;

ADRENAL GLAND; ALDOSTERONE BLOOD LEVEL; ALDOSTERONE RELEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; CONTROLLED STUDY; CORTICOTROPIN BLOOD LEVEL; DRUG RECEPTOR BINDING; ESTROGEN THERAPY; FEMALE; HEART PROTECTION; HYPOPHYSIS; MALE; NONHUMAN; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR DENSITY; SODIUM RESTRICTION;

EID: 0034520159     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.141.12.7822     Document Type: Article

References (60)

1. National High Blood Pressure Education Program Working Group Report on Hypertension in the Elderly
2. Systemic hemodynamic determinants of blood pressure in women: Age, physical activity, and hormone replacement
3. Changes in the renin-angiotensin-aldosterone axis in later life
4. Age-related change in plasma aldosterone response to exogenous angiotensin II in the rat
5. Effect of age on plasma aldosterone response to exogenous angiotensin II in normotensive subjects
6. Age-related impairment of aldosterone secretion in zona glomerulosa cells of ovariectomized rats
7. Cardiac senescence is associated with enhanced expression of angiotensin II receptor subtypes
8. Effects of aging and hypertension on plasma angiotensin II and platelet angiotensin II receptor density
9. Altered renal vascular responses in the aging rat kidney
10. Analysis of angiotensin II binding to human platelets: Differences in young and old subjects
11. Cardiovascular disease in women: A statement for healthcare professionals from the American Heart Association
12. Effects of estrogen replacement therapy on the renin-angiotensin system in postmenopausal women
13. The effects of different types and doses of oestrogen replacement therapy on clinic and ambulatory blood pressure and the renin-angiotensin system in normotensive postmenopausal women
14. Effects of chronic hormone replacement on the renin-angiotensin system in cynomolgus monkeys
15. Estrogen regulation of angiotensin-converting enzyme mRNA
16. 1 receptor gene expression in vitro and in vivo
17. Estrogen-induced refractoriness to the pressor effects of infused angiotensin II
18. Impact of gender on the renal response to angiotensin II
19. 1 receptor expression via cytosolic proteins that bind to the 5′ leader sequence of the receptor mRNA
20. Chronic estrogen treatment reduces angiotensin II receptors in the anterior pituitary
21. Estrogen effects on angiotensin receptors are modulated by pituitary in female rats
22. The role of angiotensin II in the regulation of ACTH secretion
23. The role of adrenocorticotropin in the cortisol and aldosterone responses to angiotensin II in conscious dogs
24. Plasma aldosterone and renin activity response to ACTH infusion in dexamethasone-suppressed normal and sodium-depleted man
25. Plasma aldosterone and corticosterone responses to adrenocorticotropin, angiotensin, potassium, and stress in spontaneously hypertensive rats
26. Angiotensin II infusion increases vasopressin, ACTH, and 11-hydroxycorticosteroid secretion
27. Effect of potassium, angiotensin II and ACTH on blood aldosterone and cortisol in sheep on different dietary potassium and sodium intakes
28. Control of aldosterone secretion during sodium restriction: Adrenal receptor regulation and increased adrenal sensitivity to angiotensin II
29. Nycthemeral rhythm in adrenal responsiveness to ACTH
30. Dexamethasone suppression of ACTH release: Effect of the interval between steroid administration and the application of stimuli known to release ACTH
31. Rat model for investigating ACTH-independent angiotensin-induced aldosterone secretion
32. Effects of systemic treatment with irbesartan and losartan on central responses to angiotensin II in conscious, normotensive rats
33. The influence of ovarian steroids on hypothalamic-pituitary-adrenal regulation in the female rat
34. A graphic method for the determination and presentation of binding parameters in complex systems
35. 1 receptor binding and mRNA in the female rat
36. Angiotensin II receptor subtypes and biological responses in the adrenal cortex and medulla
37. Angiotensin-II receptor subtypes in median eminence and basal forebrain areas involved in regulation of pituitary function
38. Nonpeptide angiotensin II receptor antagonists. Studies with EXP9270 and DuP 753
39. 1a angiotensin receptor gene
40. 1 receptor mRNA
41. Estrogens and the kidney
42. Estrogen influences osmotic secretion of AVP and body water balance in postmenopausal women
43. Estradiol enhances thidazide-sensitive NaCl cotransporter density in the apical plasma membrane of the distal convoluted tubule in ovariectomized rats
44. The thiazide-sensitive Na-Cl cotransporter is an aldosterone-induced protein
45. Influence of gonadal steroids on brain corticosteroid receptors: A minireview
46. Regulation of angiotensin II receptors in the rat adrenal cortex by dietary electrolytes
47. Mechanism of adrenal angiotensin II receptor changes after nephrectomy in rats
48. Potassium regulates angiotensin II-induced aldosterone biosynthesis in acutely nephrectomized rats
49. Effects of high potassium diet on angiotensin lI receptors and angiotensin-induced aldosterone production in rat adrenal glomerulosa cells
50. Maternal blood volume and cardiac output during pregnancy: A hypothesis of endocrinologic control
51. Circadian rhythms of serum renin activity and serum corticosterone, prolactin, and aldosterone concentrations in the male rat on normal and low-sodium diets
52. Progesterone-cortisol interaction in control of renin activity but not aldosterone
53. Mineralocorticoids, salt and high blood pressure
54. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure
55. Central effects of mineralocorticoid antagonist RU-28318 on blood pressure of DOCA-salt hypertensive rats
56. Intracerebroventricular infusion of RU28318 blocks aldosterone-salt hypertension
57. Brain mineralocorticoid receptor control of blood pressure and kidney function in normotensive rats
58. Neurosteroids: A new brain function?
59. The effect of spironolactone on morbidity and mortality in patients with severe heart failure